Taiwan concedes to US industry on GMP (good manufacturing practice) requirements but European companies still at a disadvantage
This article was originally published in Clinica
Executive Summary
Taiwan's Department of Health has reached an agreement with the US Health Industry Manufacturers Association (HIMA) that will allow US medical device companies to demonstrate compliance with Taiwan's planned good manufacturing practice (GMP) requirements without submitting a complete plant master file.